SCOR (SCR) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
13 Dec, 2025Executive summary
Q4 2024 net income reached EUR 233 million, with all business activities contributing positively and a proposed dividend of EUR 1.8 per share, reflecting a robust solvency ratio and capital management discipline.
FY 2024 net income was EUR 11 million, but adjusted for one-offs, net income was EUR 728 million, reflecting a 14.9% ROE; full-year results were impacted by L&H assumption review.
P&C segment delivered excellent margins and resilience, with strong underlying business performance and accelerated reserve buffer building.
Investments generated elevated returns from a high-quality fixed income portfolio, with a regular income yield at the high end of guidance.
Solvency ratio stood at 210% at year-end, fully absorbing L&H impacts and demonstrating balance sheet strength.
Financial highlights
Q4 2024 insurance revenue was EUR 4.0 billion, up 0.4% year-over-year at constant FX; net income was EUR 233 million.
FY 2024 insurance revenue reached EUR 16 billion, up 2.5% year-over-year at constant FX.
Q4 2024 combined ratio for P&C was 83.1%; FY 2024 combined ratio was 86.3%, ahead of Forward 2026 assumption.
Economic Value per share at year-end was EUR 48, down from EUR 51 at YE 2023.
FY 2024 investment income on invested assets was EUR 800 million, with a regular income yield of 3.5%.
Outlook and guidance
Forward 2026 assumptions include a P&C combined ratio below 87% and regular income yield between 3.2% and 3.6%.
L&H new business CSM generation expected at EUR 400 million per year for 2025-2026, with ramp-up in 2026.
Net capital generation guidance of 1-2 points per year for 2025 and 2026.
Further ALM actions planned in 2025 to reduce Euro interest rate sensitivities.
Dividend increases possible if economic value grows in 2025; focus remains on capital deployment, not repatriation.
Latest events from SCOR
- FY net income up to EUR 851M, ROE above 19%, dividend EUR 1.9/share, solvency 215%.SCR
Q4 20254 Mar 2026 - Q2 2024 net loss driven by L&H review, but P&C and solvency remain strong.SCR
Q2 202410 Feb 2026 - H1 2025 net income EUR 425m, ROE 20.3%, P&C combined ratio 82.5%, solvency 210%.SCR
Q2 202510 Feb 2026 - January 2026 renewals drove 14.8% EGPI growth and improved underwriting in a competitive market.SCR
Investor update4 Feb 2026 - Strong P&C and investment results offset by L&H review, solvency robust at 203%.SCR
Q3 202414 Jan 2026 - Forward 2026 targets 9% value growth, >12% ROE, higher-margin L&H, and robust solvency.SCR
Investor Day 202411 Jan 2026 - 9.6% EGPI growth driven by Specialty and Alternative Solutions, with stable profitability.SCR
Investor Update9 Jan 2026 - Q1 2025 net income hit EUR 200m, with robust solvency and strong segment performance.SCR
Q1 202518 Nov 2025 - Q3 2025 delivered EUR 217m net income, 21.5%–22.1% ROE, and a 210% solvency ratio.SCR
Q3 20252 Nov 2025